These findings highlight OS and inflammation as both a cause and consequence of IR, creating a cycle that can be interrupted by targeted antioxidant approaches and/or lifestyle interventions that enhance endogenous antioxidant capacity (see Figure 3)
and people with conditions that cause nutrient malabsorption and/or gastrointestinal blood loss (such as celiac disease, ulcerative colitis, and Crohn's disease)
In the U.S., CVD is the leading cause of death, constitutes 17% of healthcare costs, and is estimated to increase in prevalence by ~10% and direct costs by almost three-fold over the next 20 years under current CVD prevention and treatment regimes [2]
This impedes gas exchange in the liver microenvironment, inhibits NO production, causes hypoxia, and disrupts lipid metabolism, particularly the FAO, thus aggravating hepatocyte dysfunction [318]